COVID-19 Impact on Clinical Chemistry Analyzer | Healthcare Industry

Posted by Prakash on April 23rd, 2021

COVID-19 Impact on Clinical Chemistry Analyzer in Healthcare Industry

As well as the global economic environment, the COVID-19 pandemic has had an unforeseen effect on everyday life. The effect on the healthcare industry has also been dramatically changed and a huge pressure is being generated on healthcare services that are already stretched across the globe.

Emerging literature on COVID-19 shows that both in the general population and within high-risk populations, the Coronavirus pandemic has intensified psychological distress. Till July 2020, it became obvious that the novel strain of Coronavirus or COVID-19 has major impact on the healthcare system in the United States.


The demand for clinical chemistry analyzers is increasing even in this pandemic because, of its regular use and others benefits that comes with the installation of these analyzers in the laboratory.

Since most of the medicinal chemistry analyzers introduced on the market are highly automated to produce maximised throughput, improve the safety of consumers from biohazards and reduce the chance of cross-contamination. Samples are inserted into computers until the samples are installed by the customer, and experiments are conducted. In addition, the rise in demand for medical instruments in the diagnosis of different disorders (such as cardiac or neurological) contributes to an increased preference for clinical chemistry analyzers, especially in hospitals and other health facilities, and hence drives the market for clinical chemistry analyzers. Moreover, due to quicker outcomes and multiple experiments at the same time, improved accuracy of clinical chemistry analyzers has driven the global market for clinical chemistry analyzers. Read more...

Like it? Share it!


About the Author

Joined: April 19th, 2021
Articles Posted: 25

More by this author